Cite
Hackett G, Jones PW, Strange RC, et al. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes. 2017;8(3):104-111doi: 10.4239/wjd.v8.i3.104.
Hackett, G., Jones, P. W., Strange, R. C., & Ramachandran, S. (2017). Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World journal of diabetes, 8(3), 104-111. https://doi.org/10.4239/wjd.v8.i3.104
Hackett, Geoffrey, et al. "Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes." World journal of diabetes vol. 8,3 (2017): 104-111. doi: https://doi.org/10.4239/wjd.v8.i3.104
Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes. 2017 Mar 15;8(3):104-111. doi: 10.4239/wjd.v8.i3.104. PMID: 28344753; PMCID: PMC5348622.
Copy
Download .nbib